您的位置:永利手机网站 > 历史 > Bexarotene

Bexarotene

2019-04-27 15:21

 

NCT00050973

 

NCT00030589

IGCP567地震考古研究项目最新动态消息

NCT00050960

·In November 2012 we are furthermore planning an international workshop Shakin’ them off? Interdisciplinary perspectives on Minoan Earthquakes, convened by Simon Jusseret (Université Catholique de Louvain, Belgium) and Manuel Sintubin (Katholieke Universiteit Leuven, Belgium), which will take place in Leuven (Belgium).

Phase 1

· On 22 February 2012 IGCP will celebrate its 40th Anniversary at the UNESCO Headquarters in Paris. Two of our co-leaders will actively participate at this meeting. Iain Stewart (University of Plymouth, U.K.) will focus on the importance of Geosciences for Society and moderate a debate on the prospective vision for the future of IGCP. Manuel Sintubin (Katholieke Universiteit Leuven, Belgium) will reflect on the role of IGCP in geohazard mitigation based on the success of IGCP567.

NCT00425477

·The 3rd Workshop on Paleoseismology and Archaeoseismology will be held in Morelia, Mexico from 1 to 8 November 2012. More information will follow soon on the http://www.acambay1912.org.

NCT00055991

 

Dartmouth-Hitchcock Medical Center-Ligand Pharmaceuticals-Genentech, Inc.

 

Phase 1

·At the 2012 Annual Meeting of the Seismological Society of America (17-19 April, 2012, San Diego, California): Earthquakes and Tsunamis at Caostal Archaeological Sites. You find details in the following announcement (pdf ). Abstract submission deadline is 11 January 2012.

NCT00141947

 

University College, London

 

Dartmouth-Hitchcock Medical Center-Ligand Pharmaceuticals-Genentech, Inc.


Lung Cancer

For both conferences IGCP567 will most probably (depending on our funding) be able to offer travel grants.

NCT00718770

 

Non-small Cell Lung Cancer

Disclaimer: http://www.kuleuven.be/cwis/email_disclaimer.htm

"目录号: HY-14171

·At the EGU meeting (20-24 April 2012, Vienna, Austria) Matthieu Ferry (Géosciences Montpellier, France) and Kris Vanneste (ROB, Belgium) convene a session on Earthquake Geology. Abstract submission deadline is 17 January 2012.

NCT00845351

 

Boston University-Ligand Pharmaceuticals

International Geoscience Programme
IGCP 567 Earthquake Archaeology

NCT00030849

De wetenschap van de Aarde. Over een levende planeet

Phase 1

PUBLICATIONS

NCT00316030

Following our 2nd INQUA-IGCP567 International Workshop on Active Tectonics, Earthquake Geology, Archaeology and Engineering, held from 18 to 24 September 2011 in Corinth, Greece, Andreas Vött (University of Mainz, Germany) is preparing a special volume on in the Zeitschrift für Geomorphologie. This is a peer-review ISI-indexed journal and hosted up to now three special volumes on tsunamis. If you are interested to contribute to this volume, please contact Andreas Vött (voett@uni-mainz.de).

Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

 

Ligand Pharmaceuticals-NIH AIDS Clinical Trials Information Service

欢迎有对于地震考古研究和喇家遗址史前地震感兴趣的年轻朋友及时与我们联系

NCT00514293

 

The Cleveland Clinic

·At the 34th International Geological Congress (IGC), from 2 to 10 August 2012 at Brisbane, Queensland, Australia a special session is convened by Patrick Nunn (Australia), Bruce McFadgen (New Zealand), Iain Stewart (U.K.) and Manuel Sintubin (Belgium) on Natural Hazards and Ancient Societies. Abstract submission deadline is 17 February 2012.

August 2001

MEETINGS

December 2001

 

NCT01116622

 

February 2013

September 2001

Abramson Cancer Center of the University of Pennsylvania

Carcinoma, Non-small-cell Lung

December 2005

NCT01578499

Non-small Cell Lung Cancer

Lung Cancer

Phase 2

Washington University School of Medicine

August 2005

NCT01504490

European Organisation for Research and Treatment of Cancer - EORTC

NCT02061878

Phase 1

NCT00125359

ReXceptor, Inc.

Carcinoma, Non-small-cell Lung

Phase 1

Lymphoma

Phase 2

Thyroid Cancer

December 2011

Lymphoma

November 2008

November 2003

Fox Chase Cancer Center-Ligand Pharmaceuticals

NCT00002212

June 2005

NCT00151008

Dartmouth-Hitchcock Medical Center-Genentech, Inc.-Ligand Pharmaceuticals

Phase 1

Lung Cancer

Schizophrenia-Schizoaffective Disorder-Cognition

Psoriasis

November 2005

December 2011

Breast Cancer

NCT00615784

August 2014

Clinical Trial

Metabolic Enzyme/ProteaseAutophagy-

M.D. Anderson Cancer Center-United States Department of Defense

Leukemia, Myeloid, Acute

Phase 1-Phase 2

Ligand Pharmaceuticals-National Cancer Institute (NCI)

NCT01007448

Parapsoriasis

Solid Tumors-Lymphoma-Multiple Myeloma

Breast Cancer

Primary Cutaneous Anaplastic Large Cell Lymphoma-Mycosis Fungoides-Cutaneous T-Cell Lymphoma

Georgetown University-Daiichi Sankyo Inc.

Valeant Pharmaceuticals International, Inc.

Phase 1

Acute Myeloid Leukemia

NCT00055991

Phase 2

Alzheimer's Disease

May 2002

永利手机网站,Millennium Pharmaceuticals, Inc.-Seattle Genetics, Inc.-Takeda

NCT00178841

Refractory Cutaneous T-cell Lymphoma

Dartmouth-Hitchcock Medical Center-Ligand Pharmaceuticals-Genentech, Inc.

August 2005

Phase 1-Phase 2

NCT00411632

Lymphoma

Vanderbilt University

October 2001

NCT00845351

NCT00306969

NCT00238628

Bexarotene (Targretin)是维甲酸X受体(RXR)激动剂,可作用于CTCL。

NCT01782742

Phase 1

NCT00255801

Beersheva Mental Health Center

University of Medicine and Dentistry of New Jersey-Ligand Pharmaceuticals-Rutgers, The State University of New Jersey

February 2013

NCT00615784

Phase 3

Phase 3

Lymphoma

AML-Acute Myeloid Leukemia

January 2003

Solid Tumors-Lymphoma-Multiple Myeloma

Cutaneous T-cell Lymphoma-Mycosis Fungoides-Sezary Syndrome-Primary Cutaneous Anaplastic Large Cell Lymphoma

Description

Phase 2

Advanced, Malignant Aerodigestive Tract Tumor (Lung, Head and Neck and Esophagus)

NCT00125372

August 2012

Refractory Cutaneous T-cell Lymphoma

NCT01001143

August 2001

ReXceptor, Inc.

本文由永利手机网站发布于历史,转载请注明出处:Bexarotene

关键词: